8 results
Pain Assessment and Management Initiative (PAMI) - Non-Opioid Analgesics - Agents and Dosing

#Management #Pain #Pharmacology #NonOpioid
#Management # ... Pain #Pharmacology ... #NonOpioid #Analgesics ... #Medications #Doses ... #Dosing #Table
In 2018, opioid withdrawal should be considered a buprenorphine deficiency. Otherwise, a multitude of comparatively ineffective
opioid withdrawal should ... in high enough doses ... #Pharmacology # ... Pain #NonOpioid ... #Alternatives #Dosing
Taken from Dr Motov's work on a CERTA regime.
This is published in conjunction with the CERTA
and protocols should ... @Gas_Craic #Management ... #Pharmacology # ... NonOpioid #Opiate ... PainSyndromes #Pathways #Table
Rybelsus (oral semaglutide) - First Oral GLP-1 Agonist
Dosing:
3 mg daily x 30 days, then 7 mg
GLP-1 Agonist Dosing ... oral route by using ... drug to remain stable ... Patients should ... semaglutide #Diabetes #Pharmacology
IDSA Recommendations for Treating Cytomegalovirus Infections in HIV-AIDS
Preventing CMV Disease:
 • CMV end-organ disease is best
end-organ disease is best ... prevented by using ... ) for 1–4 doses ... Prevention #Treatment #management ... #HIVAIDS #pharmacology
IDSA Recommendations for Treating Mycobacterium Tuberculosis Infection and Disease in HIV-AIDS
Treating LTBI (to prevent TB disease)
Indications:
months or • RFB (dose ... empiric treatment should ... Please refer to the table ... Prevention #Treatment #management ... #HIVAIDS #pharmacology
IDSA - Clinical Strategy to Build an Individualized Treatment Regimen for Multi-Drug Resistant Tuberculosis (MDR-TB)
 •
are contacts of infectious ... isolate DST result should ... p-Aminosalicylic acid, High-dose ... Tuberculosis #MDRTB #management ... antimicrobials #regimens #pharmacology
IDSA Recommendations for Preventing and Treating Disseminated Mycobacterium Avium Complex in HIV-AIDS
Preventing 1st Episode of Disseminated
please refer to Table ... 5 for dosing recommendation ... Note: Active TB should ... opportunistic #infections ... #HIVAIDS #pharmacology